Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pamela R. Sheffels
Observed names:
P R Sheffels,
P SHEFFELS,
P Sheffels,
P. SHEFFELS,
P. Sheffels,
Pamela Bedynek,
Pamela Sheffels,
Pamela Sheffels Bedynek,
Pamela Sheffels Bedynek
show all 9
Institution:
University of Washington
Observed institutions:
University of Washington,
Washington University in St. Louis,
Norwegian University of Science and Technology,
Montana State University,
St Olav's University Hospital,
Frederick National Laboratory for Cancer Research,
National Cancer Institute
show all 7
OpenAlex ID:
A5111500488
Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone
2004
·
E KHARASCH
, C HOFFER
, et al.
·
Clinical Pharmacology & Therapeutics
·
253
Role of CYP2B6 in Stereoselective Human Methadone Metabolism
2008
·
Rheem A. Totah
, Pamela Sheffels
, et al.
·
Anesthesiology
·
205
PDF
Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: Noninvasive assessment by use of pupillary miosis
2004
·
E KHARASCH
, A WALKER
, et al.
·
Clinical Pharmacology & Therapeutics
·
128
Influence of CYP3A5 Genotype on the Pharmacokinetics and Pharmacodynamics of the Cytochrome P4503A Probes Alfentanil and Midazolam
2007
·
E D Kharasch
, A Walker
, et al.
·
Clinical Pharmacology & Therapeutics
·
107
Enantiomeric Metabolic Interactions and Stereoselective Human Methadone Metabolism
2007
·
Rheem A. Totah
, Kyle E. Allen
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
105
CYP4 Isoenzyme Specificity and the Relationship between .omega.-Hydroxylation and Terminal Desaturation of Valproic Acid
1995
·
Allan E. Rettie
, Pamela R. Sheffels
, et al.
·
Biochemistry
·
94
Methadone Pharmacokinetics Are Independent of Cytochrome P4503A (CYP3A) Activity and Gastrointestinal Drug Transport: Insights from Methadone Interactions with Ritonavir/Indinavir
2009
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
Anesthesiology
·
89
PDF
Disposition of nasal, intravenous, and oral methadone in healthy volunteers
2002
·
Ola Dale
, Christine Hoffer
, et al.
·
Clinical Pharmacology & Therapeutics
·
86
Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity
2009
·
Evan D. Kharasch
, Alysa Walker
, et al.
·
Drug and Alcohol Dependence
·
78
Bioavailabilities of rectal and oral methadone in healthy subjects
2004
·
Ola Dale
, Pamela Sheffels
, et al.
·
British Journal of Clinical Pharmacology
·
72
PDF
Metabolism of Alfentanil by Cytochrome P4503a (cyp3a) Enzymes
2004
·
Theresa Mariero Klees
, Pamela Sheffels
, et al.
·
Drug Metabolism and Disposition
·
70
Synthetic applications of Group V metallacyclopropenes. Part 1. Group V metallacyclopropenes in synthesis. An efficient route to polyfunctional ring systems via the cocyclization of diynes with substituted monoacetylenes
1989
·
Andrew C. Williams
, Pamela Sheffels
, et al.
·
Organometallics
·
45
Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5
2005
·
Theresa Mariero Klees
, Pamela Sheffels
, et al.
·
Anesthesiology
·
42
PDF
Metabolic denitrosation of N-nitrosodimethylamine in vivo in the rat.
1990
·
A J Streeter
, R W Nims
, et al.
·
PubMed
·
37
Lack of Indinavir Effects on Methadone Disposition Despite Inhibition of Hepatic and Intestinal Cytochrome P4503A (CYP3A)
2012
·
Evan D. Kharasch
, Pamela Sheffels Bedynek
, et al.
·
Anesthesiology
·
36
PDF
Sensitivity of Intravenous and Oral Alfentanil and Pupillary Miosis as Minimally Invasive and Noninvasive Probes for Hepatic and First‐Pass CYP3A Activity
2005
·
Evan D. Kharasch
, Alysa Walker
, et al.
·
The Journal of Clinical Pharmacology
·
35
Evaluation of First‐Pass Cytochrome P4503A (CYP3A) and P‐Glycoprotein Activities Using Alfentanil and Fexofenadine in Combination
2004
·
Evan D. Kharasch
, Alysa Walker
, et al.
·
The Journal of Clinical Pharmacology
·
31
Disposition and miotic effects of oral alfentanil: A potential noninvasive probe for first‐pass cytochrome P4503A activity
2003
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
Clinical Pharmacology & Therapeutics
·
31
New Insights into the Mechanism of Methoxyflurane Nephrotoxicity and Implications for Anesthetic Development (Part 1): Identification of the Nephrotoxic Metabolic Pathway
2006
·
Evan D. Kharasch
, Jesara L. Schroeder
, et al.
·
Anesthesiology
·
27
Pharmacokinetics and metabolism of the novel anticonvulsant agent N-(2,6-dimethylphenyl)-5-methyl-3-isoxazolecarboxamide (D2624) in rats and humans.
1997
·
S W Martin
, F E Bishop
, et al.
·
PubMed
·
23
Binding of flexible ligands to proteins: Valproic acid and its interaction with cytochrome P450cam
1993
·
Yan- Tyng Chang
, Gilda H. Loew
, et al.
·
International Journal of Quantum Chemistry
·
10
Decomposition and quality control considerations in biological work with fecapentaene preparations
1989
·
Anthony J. Streeter
, Paul J. Donovan
, et al.
·
Chemical Research in Toxicology
·
6
Deuterium isotope effect on the toxicokinetics of monomethylamine in the rat.
1990
·
A J Streeter
, R W Nims
, et al.
·
Drug Metabolism and Disposition
·
3
Intrasubject Variability in Intravenous and Oral Probes for Hepatic and First-Pass CYP3A Activity
2024
·
Evan D. Kharasch
, Christine Hoffer
, et al.
·
Clinical Pharmacokinetics
·
2
Role of P‐Glycoprotein in the intestinal absorption of morphine, fentanyl and methadone
2003
·
E.D. Kharasch
, D. Whittington
, et al.
·
Clinical Pharmacology & Therapeutics
·
2
Show more works
View as search
Works count:
36
Citation count:
1,621
H-index:
20
I10-index:
21
Year
Topic
Type